热门资讯> 正文

Altimmune定价2.25亿美元公开发行证券

2026-04-23 12:02

Altimmune(ALT) 0
Electrameccanica Vehicles Corp.(SOLO) 0

Altimmune (ALT) priced an oversubscribed public offering of common stock, pre-funded warrants and accompanying common stock warrants to raise approximately $225 million in gross proceeds, according to a statement late on Wednesday.
Offering includes 64.25M shares of common stock and pre-funded warrants to purchase an aggregate of up to 10.75M shares of common stock.
Each security comes with accompanying common stock warrants at exercise price of $3.00 per share. Leerink Partners and Barclays are acting as joint bookrunning managers.

More on Altimmune

Altimmune: Why I'm Downgrading To Hold Despite MASH Promise
Altimmune: Considering If A Repeat Of The 2025 Run-Up Is On Tap
Altimmune: The High Cost Of Going Solo (Rating Downgrade)
Altimmune launches proposed public offering to fund late-stage trial
Altimmune a new buy at Truist on pemvidutide promise

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。